On 7 November Activision Blizzard Inc. (NASDAQ: ATVI) announces a new multi-player game called “Overwatch,” Activision Blizzard, Inc. (NASDAQ:ATVI) in last trading activity moved up 7.87% to close at $21.11. Company weekly performance is 3.79% while its quarterly performance stands at -8.73%. Activision Blizzard, Inc. (NASDAQ:ATVI) is -12.70% away from its 52 week high.
Mobileye N.V. (NYSE:MBLY) announced financial results for the third quarter ended September 30, 2014. Total revenue for the third quarter of 2014 was $34.7 million, an increase of 70% compared to $20.4 million in the prior-year period. Within total revenue, original equipment manufacturing (OEM) revenue was $28.8 million, an increase of 60% compared to $18.0 million in the prior-year period. On last trading day Mobileye N.V. (NYSE:MBLY) decreased -5.69% to close at $44.09. Its volatility for the week is 4.72% while volatility for the month is 4.74%. Mobileye N.V. (NYSE:MBLY) monthly performance is -10.20%.
Ingersoll-Rand PLC (NYSE:IR) VP Richard Weller sold 19,582 shares of the company’s stock in a transaction that occurred on Wednesday, November 5th. The shares were sold at an average price of $62.00, for a total transaction of $1,214,084.00. Following the transaction, the vice president now directly owns 25,723 shares of the company’s stock, valued at approximately $1,594,826. On last trading day Ingersoll-Rand Plc (NYSE:IR) moved up 0.51% to close at $63.02. Its volatility for the week is 1.22% while volatility for the month is 1.68%. IR’s sales growth for past 5 years was -1.10% and its EPS growth for past 5 years was 17.50%. Ingersoll-Rand Plc (NYSE:IR) monthly performance is 9.14%.
On 6 November Actinium Pharmaceuticals, Inc. (NYSEMKT: ATNM) announced positive interim data from the ongoing Phase I/II trial of Actimab-A in older patients with newly diagnosed Acute Myeloid Leukemia (“AML”). Most notably, median overall survival (“OS”) of the seven secondary AML patients (with prior myelodysplastic syndrome, or MDS) in the study was 9.1 months, which is a prolongation of life compared to historical norms of typically 2 to 5 months.1 Older AML patients are already higher risk, with secondary AML patients considered to have the more severe and less treatable form of AML, and the shortest expected survival. Actinium Pharmaceuticals, Inc. (NYSEMKT: ATNM) has 22.51% insider ownership while its institutional ownership stands at 8.90%. In last trading activity company’s stock closed at $6.49.
Tallgrass Energy Partners LP (NYSE:TEP) was downgraded by Zacks from an “outperform” rating to a “neutral” rating in a research note issued on Monday. They currently have a $47.40 price target on the stock.Zacks‘s price objective would suggest a potential upside of 7.24% from the company’s current price. On Thursday shares of Tallgrass Energy Partners, LP (NYSE:TEP) closed at $43.50. Company’s EPS growth for next 5 years is recorded as 47.90%.